1619 related articles for article (PubMed ID: 24373340)
21. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
[TBL] [Abstract][Full Text] [Related]
22. [Thromboembolic prophylaxis 2011: is warfarin on the wane?].
Di Pasquale G; Riva L
G Ital Cardiol (Rome); 2011 Sep; 12(9):556-65. PubMed ID: 21892216
[TBL] [Abstract][Full Text] [Related]
23. Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin.
Lanitis T; Cotté FE; Gaudin AF; Kachaner I; Kongnakorn T; Durand-Zaleski I
J Med Econ; 2014 Aug; 17(8):587-98. PubMed ID: 24831811
[TBL] [Abstract][Full Text] [Related]
24. Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke.
Yoon CH; Park YK; Kim SJ; Lee MJ; Ryoo S; Kim GM; Chung CS; Lee KH; Kim JS; Bang OY
Stroke; 2014 Oct; 45(10):2983-8. PubMed ID: 25147329
[TBL] [Abstract][Full Text] [Related]
25. Practical aspects of new oral anticoagulant use in atrial fibrillation.
Undas A; Pasierski T; Windyga J; Crowther M
Pol Arch Med Wewn; 2014; 124(3):124-35. PubMed ID: 24556890
[TBL] [Abstract][Full Text] [Related]
26. Novel oral anticoagulants in non-valvular atrial fibrillation.
Potpara TS; Lip GY
Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the cost-effectiveness of new oral anticoagulants for the prevention of stroke and systemic embolism in atrial fibrillation in a UK setting.
Zheng Y; Sorensen SV; Gonschior AK; Noack H; Heinrich-Nols J; Sunderland T; Kansal AR
Clin Ther; 2014 Dec; 36(12):2015-2028.e2. PubMed ID: 25438722
[TBL] [Abstract][Full Text] [Related]
28. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
Contractor T; Levin V; Martinez MW; Marchlinski FE
Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669
[TBL] [Abstract][Full Text] [Related]
29. Risk versus benefit of non-vitamin K dependent anticoagulants compared to warfarin for the management of atrial fibrillation in the elderly.
Ogbonna KC; Jeffery SM
Drugs Aging; 2013 Jul; 30(7):513-25. PubMed ID: 23591934
[TBL] [Abstract][Full Text] [Related]
30. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
Chan KE; Edelman ER; Wenger JB; Thadhani RI; Maddux FW
Circulation; 2015 Mar; 131(11):972-9. PubMed ID: 25595139
[TBL] [Abstract][Full Text] [Related]
31. Primary prevention of ischaemic stroke in atrial fibrillation: new oral anticoagulant drugs for all?
Foley J; Kirchhof P; Lip GY
Curr Vasc Pharmacol; 2014 May; 12(3):373-83. PubMed ID: 24846226
[TBL] [Abstract][Full Text] [Related]
32. Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications.
Desai NR; Krumme AA; Schneeweiss S; Shrank WH; Brill G; Pezalla EJ; Spettell CM; Brennan TA; Matlin OS; Avorn J; Choudhry NK
Am J Med; 2014 Nov; 127(11):1075-1082.e1. PubMed ID: 24859719
[TBL] [Abstract][Full Text] [Related]
33. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
Kimachi M; Furukawa TA; Kimachi K; Goto Y; Fukuma S; Fukuhara S
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011373. PubMed ID: 29105079
[TBL] [Abstract][Full Text] [Related]
34. New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures.
Coccheri S; Orlando D
Intern Emerg Med; 2013 Mar; 8(2):115-22. PubMed ID: 23247681
[TBL] [Abstract][Full Text] [Related]
35. Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.
Kosar L; Jin M; Kamrul R; Schuster B
Can Fam Physician; 2012 Aug; 58(8):850-8. PubMed ID: 22893338
[No Abstract] [Full Text] [Related]
36. Novel anticoagulants vs warfarin for stroke prevention in atrial fibrillation.
Turagam MK; Velagapudi P; Bongu NR; Kocheril AG
Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):79-86. PubMed ID: 25088126
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulation in atrial fibrillation.
Steinberg BA; Piccini JP
BMJ; 2014 Apr; 348():g2116. PubMed ID: 24733535
[TBL] [Abstract][Full Text] [Related]
38. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
[TBL] [Abstract][Full Text] [Related]
39. A new era of antithrombotic therapy in patients with atrial fibrillation.
Golwala H; Dib C; Tafur A; Abu-Fadel MS
Am J Med Sci; 2012 Aug; 344(2):128-35. PubMed ID: 22245946
[TBL] [Abstract][Full Text] [Related]
40. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
